Literature DB >> 25376309

Rehabilitation for paraplegia caused by neuromyelitis optica: a case report.

M Sato1, K Sugiyama1, T Kondo1, S-I Izumi1.   

Abstract

STUDY
DESIGN: Single case report.
OBJECTIVE: We present a case of paraplegia due to neuromyelitis optica (NMO) with poor rehabilitation outcome.
SETTING: University hospital, Japan. CASE REPORT: A 27-year-old woman with NMO presented with T5 paraplegia of ASIA impairment scale grade A. Spinal cord magnetic resonance imaging revealed a lesion spanning C3 to L1 level. After acute phase treatment, flaccid paraplegia below T5 and a T2-weighted hyperintense lesion from T6 to T10 level remained. Rehabilitation aimed at independence of activities of daily living with wheelchair assistance, including transfer activity, was provided for 19 months. However, flaccid paralysis of the trunk and limbs persisted, and safe independent transfer was not achieved.
CONCLUSION: Spinal lesions spanning many vertebral segments, a characteristic of NMO, can cause extensive flaccid paralysis of the trunk and limbs. Rehabilitation may achieve poorer functional recovery than that for spinal cord injury.

Entities:  

Mesh:

Year:  2014        PMID: 25376309     DOI: 10.1038/sc.2014.139

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  3 in total

1.  Inpatient Multidisciplinary Rehabilitation Intervention Outcomes for Neuromyelitis Optica Spectrum Disorder: A Retrospective Observational Study.

Authors:  Junko Ikeda; Yumiko Kaseda; Takanori Namba; Mitsuhiro Ochi; Miwa Hayata; Tatsuo Kohriyama
Journal:  Prog Rehabil Med       Date:  2016-11-09

Review 2.  Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders.

Authors:  Andrea Salazar-Camelo; Naveen George; Hesham Abboud; Sarah M Planchon; Marcelo Matiello; Maureen A Mealy; Andrew Goodman
Journal:  J Neurol       Date:  2021-09-05       Impact factor: 4.849

3.  Physical therapy for a patient with neuromyelitis optica during the acute phase: A case report.

Authors:  Yuichi Nishikawa; Noriaki Maeda; Hiroaki Kimura
Journal:  SAGE Open Med Case Rep       Date:  2021-05-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.